Tubular adenoma and intramucosal intestinal-type adenocarcinoma of the stomach: what are the pathobiological differences? Satoru KaseMitsuhiko OsakiHisao Ito Original article Pages: 71 - 79
Western body mass indices need not compromise outcomes after modified D2 gastrectomy for carcinoma Jonathan D. BarryGuy R.J.C. BlackshawMiles C. Allison Original article Pages: 80 - 85
Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer Yoshihiko KitajimaKohji MiyazakiMutsuo Sekiguchi Original article Pages: 86 - 95
Effect of mucosal suture on the healing of mucosal defect in laparoscopic intragastric surgery Takeyoshi YumibaToshinori itoHikaru Matsuda Original article Pages: 96 - 99
Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy Norio MatsukuraTakashi TajiriNobutaka Yamada Original article Pages: 100 - 107
Absence of beta-tubulin gene mutation in gastric carcinoma Naomi UranoYoshiyuki FujiwaraMorito Monden Original article Pages: 108 - 112
Endoscopic mucosal resection (EMR) for the management of poorly differentiated adenocarcinoma of the stomach: a patient who had recurrence and died 4 years after EMR Satoshi MurakamiSatoshi TanabeHiroyuki Mitomi Case report Pages: 113 - 116
Weekly paclitaxel for a patient with advanced gastric cancer Shigetaka YamamotoYasuhiro TanakaYoujirou Kurihara Case report Pages: 117 - 121
Imatinib (STI-571) heals a gastrocutaneous fistula resulting from a malignant gastric stromal tumor Enders K.W. NgSimon K.H. WongS.C. Sydney Chung Case report Pages: 122 - 126